Misleading gene conversion frequencies due to a PCR artifact using small fragment homologous replacement

被引:18
作者
De Semir, D [1 ]
Aran, JM [1 ]
机构
[1] Hosp Llobregat, Hosp Duran & Reynals, IRO, Ctr Genet Med & Mol, Barcelona 08907, Spain
关键词
D O I
10.1089/154545703322460630
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies have reported successful correction of the most common F508del mutation in cystic fibrosis (CF) airway epithelial cells by small fragment homologous replacement (SFHR). We wished to apply the SFHR methodology to our CF bronchial epithelial cells, of compound heterozygous genotype (F508del/W1282X), in which nucleic acid transfer was previously optimized by electroporation. Using a PCR-based detection methodology, with one of the primers located outside the SFHR homology region, we obtained SFHR dose-dependent F508del to wild-type CFTR gene conversion frequencies reaching 30%. However, the increased wild-type/F508del CFTR allele ratio was transient, vanishing at 5 days posttransfection. Furthermore, we have been unable to reproduce the SFHR-mediated repair of the F508del mutation in our cellular model when both detection primers were located outside the SFHR homology region. A thorough reexamination of our initial detection strategy revealed that a false positive result was originated from a PCR artifact created by the SFHR fragment itself. Thus, nonamplifiable detection methods, such as Southern blotting, protein analysis, or functional assays, should be performed, whenever possible, to correctly assess gene conversion frequencies.
引用
收藏
页码:261 / 269
页数:9
相关论文
共 32 条
[1]   Chimeraplasty validation [J].
Albuquerque-Silva, J ;
Vassart, G ;
Lavinha, J ;
Abramowicz, MJ .
NATURE BIOTECHNOLOGY, 2001, 19 (11) :1011-1011
[2]   Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line [J].
Bedwell, DM ;
Kaenjak, A ;
Benos, DJ ;
Bebok, Z ;
Bubien, JK ;
Hong, J ;
Tousson, A ;
Clancy, JP ;
Sorscher, EJ .
NATURE MEDICINE, 1997, 3 (11) :1280-1284
[3]   Targeted correction of a defective selectable marker gene in human epithelial cells by small DNA fragments [J].
Colosimo, A ;
Goncz, KK ;
Novelli, G ;
Dallapiccola, B ;
Gruenert, DC .
MOLECULAR THERAPY, 2001, 3 (02) :178-185
[4]   Non-viral vector-mediated uptake, distribution, and stability of chimeraptasts in human airway epithelial cells [J].
de Semir, D ;
Petriz, J ;
Avinyó, A ;
Larriba, S ;
Nunes, V ;
Casals, T ;
Estivill, X ;
Aran, JM .
JOURNAL OF GENE MEDICINE, 2002, 4 (03) :308-322
[5]   Suitability of oligonucleotide-mediated cystic fibrosis gene repair in airway epithelial cells [J].
de Semir, D ;
Nadal, M ;
González, JR ;
Larriba, S ;
Avinyó, A ;
Nunes, V ;
Casals, T ;
Estivill, X ;
Aran, JM .
JOURNAL OF GENE MEDICINE, 2003, 5 (07) :625-639
[6]   Application of SFHR to gene therapy of monogenic disorders [J].
Goncz, KK ;
Prokopishyn, NL ;
Chow, BL ;
Davis, BR ;
Gruenert, DC .
GENE THERAPY, 2002, 9 (11) :691-694
[7]   Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments [J].
Goncz, KK ;
Kunzelmann, K ;
Xu, ZD ;
Gruenert, DC .
HUMAN MOLECULAR GENETICS, 1998, 7 (12) :1913-1919
[8]   Expression of ΔF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR [J].
Goncz, KK ;
Colosimo, A ;
Dallapiccola, B ;
Gagné, L ;
Hong, K ;
Novelli, G ;
Papahadjopoulos, D ;
Sawa, T ;
Schreier, H ;
Wiener-Kronish, J ;
Xu, Z ;
Gruenert, DC .
GENE THERAPY, 2001, 8 (12) :961-965
[9]  
GONCZ KK, 2001, BIOTECHNOLOGY, V3, P113
[10]  
GONCZ KK, 1998, GENE TARGETING VECTO, P85